Nasdaq Nordic: Nasdaq Stockholm Welcomes OncoZenge to the Nasdaq First North Growth Market
Stockholm, February 12, 2020 - Nasdaq (Nasdaq: NDAQ) announces that trading in
OncoZenge AB's shares (short name ONCOZ) commences today on Nasdaq First North
Growth Market. The company belongs to the Health Care segment. OncoZenge is the
8th company to be admitted to trading on Nasdaq's Nordic markets* in 2021.
Oncozenge develops superior products for cancer supportive care. OncoZenge is a
Swedish pharmaceutical company founded in 2020 originating from a collaboration
between Moberg Pharma and leading clinicians from Hvidovre Hospital in Denmark.
BupiZenge can radically improve quality of life for patients with severe oral